Improving Staging in Bladder Cancer: The Increasing Role of Multiparametric Magnetic Resonance Imaging

Panebianco, Valeria; Barchetti, Flavio; Haas, Robbert J. de; Pearson, R.; Kennish, Steven; Giannarini, Gianluca; Catto, James W.F.

doi:10.1016/j.euf.2016.04.010

Cited by 72 publications

(52 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, patients with discordant radiological and histological stages can be identified and prioritized for re-resection. Few authors have examined the role imaging to guide of re-resection, but advances in multiparametric MRI of the bladder suggest this may become central to management in the future [22]. Technology, such as diffusion weighting and dynamic contrast enhancement, has improved the ability of MRI to differentiate pT1 from pT2 disease in up to 90% of patients [23].…”

Section: Discussionmentioning

confidence: 99%

Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use

Gordon

Thomas

Noon

et al. 2019

European Urology Focus

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use

Gordon

Thomas

Noon

et al. 2019

European Urology Focus

Self Cite

View full text Add to dashboard Cite

show abstract

“…No distention, as well as overdistension, might lead to a misdiagnosis or over staging of any tumours that are present. Optimally, the bladder should contain~300 mL at the time of the MRI [14].…”

Section: The Development Of Vi-radsmentioning

confidence: 99%

The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review

Carando

Afferi

Marra

et al. 2020

Arab Journal of Urology

View full text Add to dashboard Cite

2020) The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review, ABSTRACT Objective: To evaluate the role of the Vesical Imaging-Reporting and Data System (VI-RADS) score in the diagnostic pathway of bladder cancer. Methods: A systemic search of the contemporary literature was performed in December 2019 using the Medical Literature Analysis and Retrieval System Online (MEDLINE), the Excerpta Medica dataBASE (EMBASE), and Web of Science databases focussing on all available articles on VI-RADS.Results: Overall, six of 15 articles were included. All the available articles evaluated the ability of radiologists to use the VI-RADS score for discriminating non-muscle-invasive bladder cancer (NMIBC) from muscle-invasive bladder cancer (MIBC). Considering a cut-off VI-RADS score of >2, the sensitivity, specificity, positive (PPV) and negative predictive value (NPV) were 78-91.9%, 85-91%.1, 69-78%, and 88-97.1%, respectively. Considering a VI-RADS score cut-off of >3, the sensitivity, specificity, PPV and NPV were 77-94.6%, 43.9-96.5%, 51.6-86%, and 63.7-93%, respectively. Good interobserver agreement was demonstrated in the evaluated studies with a κ score of 0.73-0.89. Only one study evaluated the utility of VI-RADS in determining the presence of MIBC in patients treated with transurethral resection of the bladder diagnosed with high-grade T1 before the second transurethral resection using a VI-RADS score cut-off of >2; the sensitivity, specificity, PPV and NPV were 85%, 93.6%, 74.5%, and 96.6%, respectively. Conclusion: The VI-RADS score, using multiparametric magnetic resonance imaging, showed excellent results in discriminating MIBC from NMIBC. Preliminary results have been reported for its use in patients with high-grade T1 bladder cancer. These results need to be validated in high-quality real-world settings.Abbreviations: DCE: dynamic contrast enhancement; DWI: diffusion-weighted imaging; (N) MIBC: (non-)muscle-invasive bladder cancer; mpMRI: multiparametric MRI; TURBT: transurethral resection of bladder tumour; (N)(P)PV: (negative) (positive) predictive value; SC: structural category; T2W: T2-weighted; VI-RADS: vesical imaging-reporting and data system ARTICLE HISTORY

show abstract

“…300 ml) wird eine gute Abbildung der Blasenwand und Detrusormuskulatur ermöglicht. Hierzu soll der Patient spätestens 1 h vor der Aufnahme miktionieren oder 30 min vor der Untersuchung etwa 0,5 l Wasser trinken [24]. Zur Unterdrückung der Darmperistaltik und Harnblasenbewegung wird die i.v.-Applikation von Buscopan empfohlen.…”

Section: Multiparametrische Mrt-untersuchung Beim Urothelkarzinomunclassified

“…Das mpMRT besteht aus morphologischen, hochauflösenden T2w-Sequenzen sowie weiteren funktionellen Darstellungen mittels diffusionsgewichteter MRT (DWI) und dynamischer kontrastmittelgestützter MRT (DCE). Die Kombination von anatomischen und funktionellen Sequenzen verbessert die Genauigkeit des lokalen Tumorstagings im Vergleich zur konventionellen Bildgebung alleine [24]. Alle Aufnahmen sollten die gesamte Harnblase, die proximale Urethra, pelvine Lymphknoten sowie die Prostata bei Männern und angrenzende Organe (Uterus, Adnexe, Vagina) bei Frauen beinhalten.…”

Section: Multiparametrische Mrt-untersuchung Beim Urothelkarzinomunclassified

The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics—status quo

Hechler

Rink

Beyersdorff

et al. 2019

Urologe

View full text Add to dashboard Cite

Improving Staging in Bladder Cancer: The Increasing Role of Multiparametric Magnetic Resonance Imaging

Cited by 72 publications

References 51 publications

Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use

Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use

The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review

The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics—status quo

Contact Info

Product

Resources

About